Insights Into Glucocorticoid-Associated Hypertension

Area of Science:

• Endocrinology
• Nephrology
• Cardiovascular Physiology

Background:

• The link between excess glucocorticoids and hypertension is established but not fully understood.
• Glucocorticoids impact multiple blood pressure regulation sites.
• 11-beta-hydroxysteroid dehydrogenase (11-beta-HSD) enzymes metabolize glucocorticoids, controlling receptor access.

Purpose of the Study:

• To elucidate the mechanisms by which glucocorticoids influence blood pressure regulation.
• To investigate the role of 11-beta-HSD in glucocorticoid-mediated effects on sodium transport and vascular resistance.

Main Methods:

• Review of clinical observations and laboratory studies.
• Analysis of glucocorticoid effects on renal tubular sodium transport.
• Examination of glucocorticoid actions on vascular tissue responses to vasoconstrictors.

Main Results:

• Inhibition of 11-beta-HSD enhances glucocorticoid-induced sodium transport in the kidney.
• Glucocorticoids increase Na(+), K(+) ATPase and Na(+)-H(+) exchanger expression in proximal tubules, potentiating angiotensin II effects.
• Glucocorticoids can bind to mineralocorticoid receptors in distal renal segments.
• In vascular tissue, glucocorticoids upregulate vasoconstrictor receptors and downregulate vasodilator effects, magnifying responses to vasoconstrictors.

Conclusions:

• Glucocorticoids alter both circulating volume and vascular resistance, contributing to hypertension.
• 11-beta-HSD plays a critical role in modulating glucocorticoid action in various tissues.
• Understanding these mechanisms is key to managing glucocorticoid-induced hypertension.